Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203

Partial Replicated Crossover Clinical Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203 Treatment to Those of Co-administration of Eperisone Hydrochloride Slow Release and Aceclofenac in Volunteers

Status

Withdrawn

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02289274

Acronym

NVP-1203

Enrollment

Registered

2014-11-13

Start date

2019-11-30

Completion date

2019-12-31

Last updated

2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The purpose of this study is to compare the pharmacokinetics of NVP-1203 and coadministration of aceclofenac and eperisone HCl SR.

Detailed description

aceclofenac and eperisone(low back pain)

Interventions

DRUGNVP-1203

NVP-1203(eperisone SR + aceclofenac)

DRUGEperisone SR tab. + and Airtal tab.

Eperisone SR and aceclofenac

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

19 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy male volunteers, age between 19 and 45 * BMI of \>19kg/m2 and \<28kg/m2 subject * Informed of the investigational nature of this study and voluntarily agree to participate in this study

Exclusion criteria

* Use of any prescription medication within 14 days prior to Day 1 * Use of any medication within 7 days prior to Day 1

Design outcomes

Primary

Measure	Time frame
Area Under Curve(AUC) last	0-24hr

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026